I am a healthcare professional
If you are a healthcare professional looking to find out more about heavy menstrual bleeding and contraception, please click below.
HCP

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer logo

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Online learning

A digital learning environment with CPD-accredited modules in women’s health

Keeping abreast of the latest thinking in women’s health can be challenging to fit in your working day. This online learning hub provides you with access to high-quality, educational content that you can complete at a time that suits you. Regularly updated with new and engaging content, from e-learning courses that support you in counselling your patients to full FSRH-registered diplomas, there is something here to suit everyone’s training needs.

These e-learning modules are intended for UK healthcare professionals providing sexual and reproductive healthcare in community, primary and secondary care settings. Many of the modules are CPD accredited.

Just click start module to begin!

coming soon
Heavy menstrual bleeding (HMB): evidence-based learning for best practice

Heavy menstrual bleeding (HMB): evidence-based learning for best practice

A 30-minute, scientific e-learning course developed by the HELP expert panel of independent physicians*. Three case-based modules cover the diagnostic pathway and treatment algorithm for HMB to help you to counsel your patients effectively.

*The formation of the HELP expert panel and its ongoing work is supported by Bayer AG.

coming soon
The Bayer intrauterine techniques training programme

The Bayer intrauterine techniques training programme

Practical training and support for GPs and nurses who wish to gain their letter of competence in intrauterine techniques (LoC IUT) and complete the faculty of sexual and reproductive healthcare (FSRH) diploma.

coming soon
Contraception and IUS counselling

Contraception and IUS counselling

This eLearning module covers how to successfully counsel women around contraception focusing on Intrauterine contraception – the IUS. 

coming soon
Addressing the myths of intrauterine contraception (IUC)

Addressing the myths of intrauterine contraception (IUC)

Patient misconceptions are a common reason why IUC are not more widely used, despite being recommended as a first-line treatment option for HMB*1,2. This web conference takes a look at the evidence that can help you to combat patient concerns and assess suitable long-term treatment options.

*For women with no identified pathology, fibroids less than 3 cm in diameter, or suspected or diagnosed adenomyosis.2

coming soon
Case-based learning: individualising care to meet your patients’ needs

Case-based learning: individualising care to meet your patients’ needs

Three relatable case studies to help you determine the right diagnostic pathway and the most appropriate treatment options for the different patient types in your clinic.

Recommendations

Upcoming webinars

Read more

Counselling patients

Read more

References

  1. Black K, et al. Eur J Contracept Reprod Health Care 2012;17:340–350.
  2. NICE guideline NG88: Heavy menstrual bleeding. Available at: https://www.nice.org.uk/guidance/ng88/chapter/Recommendations#management-of-hmb. Last accessed: October 2019.

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

  • PP-PF-WHC-GB-0251 November 2019

Copyright © 2019,
Bayer plc

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess® (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

Page last modified Tue, 06/02/2020 - 05:14

Bayer logo